Paul Tudor Jones's IDYA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 42,705 shares of IDEAYA Biosciences, Inc. (IDYA) worth $1.42 M, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in IDYA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 37,595 shares. Largest reduction occurred in Q4 2023, reducing 20,931 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's IDEAYA Biosciences (IDYA) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEAYA Biosciences (IDYA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -5,233 | Reduce 10.92% | 42,705 | $33.32 |
| Q4 2025 | +10,343 | Add 27.51% | 47,938 | $34.57 |
| Q3 2025 | +37,595 | New Buy | 37,595 | $27.21 |
| Q4 2023 | -20,931 | Sold Out | 0 | $0.00 |
| Q3 2023 | +20,931 | New Buy | 20,931 | $26.98 |
Paul Tudor Jones's IDEAYA Biosciences Investment FAQs
Paul Tudor Jones first purchased IDEAYA Biosciences, Inc. (IDYA) in Q3 2023, acquiring 20,931 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held IDEAYA Biosciences, Inc. (IDYA) for 5 quarters since Q3 2023.
Paul Tudor Jones's largest addition to IDEAYA Biosciences, Inc. (IDYA) was in Q3 2025, adding 37,595 shares worth $1.02 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 42,705 shares of IDEAYA Biosciences, Inc. (IDYA), valued at approximately $1.42 M.
As of the Q1 2026 filing, IDEAYA Biosciences, Inc. (IDYA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in IDEAYA Biosciences, Inc. (IDYA) was 47,938 shares, as reported at the end of Q4 2025.